Oct 21, 2019
Theravance Biopharma and Mylan to Present New Data on YUPELRI® (revefenacin) at the 2019 CHEST Annual Meeting
Oct 21, 2019
Visiongain Report Researches Growth Opportunities Within the $138bn Pharmaceutical Contract Manufacturing Market
Oct 17, 2019
Visiongain Report Looks at Opportunities Within the $32bn Ophthalmic Drugs Market
Oct 02, 2019
Visiongain Report Researches Growth Opportunities Within the $235bn OTC Pharmaceutical Market
Oct 01, 2019
Lannett Enters Into Distribution Agreement For Generic ADVAIR DISKUS®
Sep 27, 2019
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission
Sep 17, 2019
Mylan Expands Oncology Portfolio with Launch of Generic Faslodex® Injection, a Treatment for Advanced Breast Cancer
Aug 21, 2019
Visiongain Report Researches Growth Opportunities Within the $424bn Generic Drugs Market
Jul 31, 2019
Theravance Biopharma, Inc. Reports Second Quarter 2019 Financial Results and Provides Business Update
Jul 31, 2019
European CNS Specialist Neuraxpharm Launches First Products in the United Kingdom
Jul 30, 2019
Revenues For Connected Medical Device Market Expected to Reach $6 Billion
Jul 29, 2019
Statement from Mylan's Board of Directors Regarding Retirement of CEO and Board Member Heather Bresch in Conjunction with the Combination of Mylan and Upjohn, a Division of Pfizer
Jul 08, 2019
Mylan and Atomo Diagnostics Announce WHO Prequalification Approval for Mylan HIV Self Test
Jun 14, 2019
Theravance Biopharma and Mylan Expand YUPELRI® (revefenacin) Development and Commercialization Agreement to Include China and Adjacent Territories
Jun 06, 2019
Visiongain Report Provides Critical Market-led Data on the $36bn Dermatological Drugs Market
May 28, 2019
Global Transdermal Patch Market Valued at 8151 Million USD in 2018 With a CAGR of 3.12% by 2025 - Valuates Reports
May 20, 2019
Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International Conference
May 18, 2019
Mylan Presents Equivalence and Device Usability Data on Wixela(TM) Inhub(TM) Compared to Advair Diskus® at American Thoracic Society International Conference
May 14, 2019
Biotech Stocks: Latest Technological Developments Pushing U.S. Medical Device Market to New Levels
May 10, 2019
Mylan Expands Oncology Portfolio with Launch of Generic Tarceva® Tablets